Edwards Lifesciences Corp Stock Alpha and Beta Analysis
| EW Stock | USD 71.27 0.79 1.12% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Edwards Lifesciences Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Edwards Lifesciences over a specified time horizon. Remember, high Edwards Lifesciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Edwards Lifesciences' market risk premium analysis include:
Beta 0.18 | Alpha (0.04) | Risk 1.6 | Sharpe Ratio 0.0449 | Expected Return 0.072 |
Edwards Lifesciences Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Edwards |
Edwards Lifesciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Edwards Lifesciences market risk premium is the additional return an investor will receive from holding Edwards Lifesciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Edwards Lifesciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Edwards Lifesciences' performance over market.| α | -0.04 | β | 0.18 |
Edwards Lifesciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Edwards Lifesciences' Buy-and-hold return. Our buy-and-hold chart shows how Edwards Lifesciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Edwards Lifesciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Edwards Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Edwards Lifesciences shares will generate the highest return on investment. By understating and applying Edwards Lifesciences stock market price indicators, traders can identify Edwards Lifesciences position entry and exit signals to maximize returns.
Edwards Lifesciences Return and Market Media
The median price of Edwards Lifesciences for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 68.13 with a coefficient of variation of 2.55. The daily time series for the period is distributed with a sample standard deviation of 1.74, arithmetic mean of 67.92, and mean deviation of 1.49. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule 16b-3 | 08/30/2024 |
2 | Levi Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation of a Class Action Lawsuit and an Upcoming Deadline | 11/13/2024 |
3 | After Losing Over 16 Billion Of Market Capitalization Edwards Lifesciences Faces Investor ... | 11/18/2024 |
4 | ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to ... | 11/19/2024 |
5 | Edwards Lifesciences Corporation Sued for Securities Law Violations Investors Should Contact Levi Korsinsky for More Information EW | 11/20/2024 |
6 | EW LAWSUIT ALERT Levi Korsinsky Notifies Edwards Lifesciences Corporation Investors of a ... | 11/21/2024 |
7 | Faruqi Faruqi Reminds Edwards Lifesciences Corporation Investors of the Pending Class ... | 11/22/2024 |
About Edwards Lifesciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Edwards or other stocks. Alpha measures the amount that position in Edwards Lifesciences Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 46.38 | 47.41 | 50.87 | 60.19 | PTB Ratio | 13.84 | 7.95 | 6.96 | 4.82 |
Edwards Lifesciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Edwards Lifesciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Edwards Lifesciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Edwards Lifesciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Edwards Lifesciences. Please utilize our Beneish M Score to check the likelihood of Edwards Lifesciences' management manipulating its earnings.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Edwards Lifesciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.